Memantine Market Remarking Enormous Growth with Current Trends & Demands through 2026

-
Memantine
Memantine

Memantine is a non-acetyl cholinesterase inhibitor that helps with Alzheimer's disease treatment. The medicine was approved for sale in Europe in 2002 and the United States Food and Drug Administration (US FDA) in 2003. Since 2015, generic versions of the medications have been accessible. Memantine is used to treat Alzheimer's disease-related dementia, which ranges from mild to severe. However, chronic use of the medication may result in a serious skin reaction known as Stevens-Johnson syndrome (characterised by painful blisters on the skin).

Drivers of the Memantine Market

The Memantine Market is likely to rise as the number of pipeline studies for its application grows. For example, in September 2016, Lille University Hospital began a phase I clinical trial to evaluate the effects of memantine on cognitive behaviour in Alzheimer's disease patients. The research is expected to be finished in February 2019. Suven Life Sciences Limited is also conducting a phase II clinical trial to compare the safety and efficacy of SUVN-502 versus memantine HCl and donepezil HCl in the treatment of moderate Alzheimer's disease. The research began in September 2015 and is slated to end in May 2019.

Restraint in the Memantine Market

The growing number of pharmacological patents that have expired is a key stumbling block to the Global Memantine Market Expansion. According to Merz Pharmaceuticals, a German company, overall licence income for memantine during the patented period declined in October 2018 due to the end of patent protection in the majority of markets. According to Merz Pharmaceuticals, licence income for memantine in the United States fell to US$ 138.07 million in 2017-18, down from US$ 183.34 million the previous year.

Regional Analysis of the Memantine Market

The global Memantine Market is divided into five regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Because of the increasing number of generic versions of memantine on the market in the United States, North America is likely to keep a dominating position in the worldwide market for memantine. For example, Lupin Limited announced the launch of its Memantine Hydrochloride Extended-Release Capsules in the United States in February 2018. The capsules come in seven different strengths: 7 mg, 14 mg and 21 mg. These are for the treatment of Alzheimer's disease dementia, which ranges from mild to severe.

Comments

Post a Comment

Popular posts from this blog

Endometrial Ablation Market Analysis, Industry Scope, Global Opportunity Analysis and Forecast Till 2027

-
Image
Endometrial Ablation Market Endometrial ablation is a procedure used to treat abnormally high uterine bleeding that cannot be managed by medicine by facilitating the destruction of the endometrium, a thin layer of the uterine wall. According to the American College of Obstetrics and Gynecology, Endometrial Ablation Market is not indicated for women who have endometrial diseases, endometrial hyperplasia, uterine cancer, a recent pregnancy, and specific uterine infections (ACOG). There are various endometrial ablation procedures available, including radiofrequency, heated fluid, heated balloon, electrosurgery, freezing, and microwave ablation techniques, depending on the technique and kind of patient being treated. The easy access to recently developed sophisticated ablation technology, convenience of use, shorter treatment times, and outpatient facilities, North America dominates the Endometrial Ablation Market . Endometrial ablation devices would see a sharp rise in global adoption d...
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f...
Read more

Artificial Intelligence And Machine Learning Are Fueling Growth Of Assessment Services Market

-
Image
Assessment Services Market The global Assessment Services Market is estimated to be valued at US$ 14.83 Bn in 2022 and is expected to exhibit a CAGR of 9.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Assessment services help companies evaluate candidates for recruitment based on attributes like critical thinking, decision making, problem solving etc. Employers use these tools to hire best talent aligned with organizational goals and culture. Services include cognitive ability tests, personality tests, situational judgement tests, remote proctoring and AI powered video interviews. Market key trends: The growing adoption of data-driven talent selection strategies coupled with developments in AI and machine learning is driving demand for assessment services. Use of algorithms and neural networks powered by big data helps analyze candidate attributes and person-organization fit more objectively. Virtual asses...
Read more